Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
NeoGenomics, Inc. - Common Stock
(NQ:
NEO
)
13.78
+1.15 (+9.11%)
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about NeoGenomics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Why NeoGenomics Shares Are Trading Higher Today
February 23, 2023
Via
Benzinga
Why Domino's Pizza Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
February 23, 2023
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
February 23, 2023
Via
Benzinga
NeoGenomics Reports Fourth Quarter and Full Year 2022 Results
February 23, 2023
Via
ACCESSWIRE
Analyst Expectations for NeoGenomics's Future
February 01, 2023
Via
Benzinga
US Stocks Turn Lower; Dow Drops 150 Points
February 23, 2023
U.S. stocks turned lower midway through trading, with the Dow Jones dropping around 150 points on Thursday. The Dow traded down 0.47% to 32,889.30 while the NASDAQ fell 0.47% to 11,452.63. The S&P 500...
Via
Benzinga
Comfort Systems, Gannett, CommScope And Other Big Stocks Moving Higher On Thursday
February 23, 2023
U.S. stocks traded slightly lower, with the Dow Jones dropping around 30 points on Thursday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of NeoGenomics Laboratories, Inc. (NEO) Investigation
February 08, 2023
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Earnings Scheduled For February 23, 2023
February 23, 2023
Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter.
Via
Benzinga
NeoGenomics, Inc. (NASDAQ:NEO) Investor Notice: Deadline in Lawsuit on February 6, 2023
February 06, 2023
San Diego, CA -- (SBWIRE) -- 02/06/2023 -- The Shareholders Foundation announced that a deadline is coming up on February 6, 2023 in the lawsuit filed for certain investors of NeoGenomics, Inc....
Via
SBWire
NEO FINAL DEADLINE TODAY: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages NeoGenomics, Inc. Investors to Secure Counsel Before Important February 6 Deadline in Securities Class Action - NEO
February 06, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
Exposures
Financial
Legal
Final Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Notifies NeoGenomics, Inc. (NEO) Investors of Class Action and to Actively Participate
February 06, 2023
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
NeoGenomics Schedules its Fourth Quarter and Full Year 2022 Earnings Release for February 23, 2023
February 06, 2023
Via
ACCESSWIRE
RaDaR(R) Assay Demonstrates Clinical Potential for Helping Oncologists Determine Whether or Not Muscle-Invasive Bladder Cancer Patients Undergo Radical Surgery
February 06, 2023
Via
ACCESSWIRE
NEO DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages NeoGenomics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important February 6 Deadline in Securities Class Action - NEO
February 04, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
NEOGENOMICS 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess Of $100,000 of Deadline in Class Action Lawsuit Against NeoGenomics, Inc. - NEO
February 03, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
NEOGENOMICS DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against NeoGenomics, Inc. and Encourages Investors to Contact the Firm
February 03, 2023
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against F45 Training, Silvergate, NeoGenomics, and Iris and Encourages Investors to Contact the Firm
February 03, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against NeoGenomics, Inc. (NEO)
February 03, 2023
From
The Law Offices of Frank R. Cruz
Via
Business Wire
NEO FINAL DEADLINE NOTICE: ROSEN, A LEADING AND RANKED FIRM, Encourages NeoGenomics, Inc. Investors with Losses to Secure Counsel Before Important February 6 Deadline in Securities Class Action - NEO
February 02, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
Exposures
Financial
Legal
Benzinga's Top Ratings Upgrades, Downgrades For February 1, 2023
February 01, 2023
Via
Benzinga
NEO FINAL DEADLINE NOTICE: ROSEN, NATIONAL TRIAL ATTORNEYS, Encourages NeoGenomics, Inc. Investors with Losses to Secure Counsel Before Important February 6 Deadline in Securities Class Action - NEO
January 31, 2023
WHY: NEW YORK, NY - (NewMediaWire) - January 31, 2023 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of NeoGenomics, Inc. (NASDAQ: NEO) between February 27,...
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against F45 Training, Silvergate, NeoGenomics, and Iris and Encourages Investors to Contact the Firm
January 29, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
NEO FINAL DEADLINE ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages NeoGenomics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NEO
January 27, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
Exposures
Financial
Legal
NEO INVESTOR ALERT: First and Only NeoGenomics Class Action Filed by Gibbs Law Group
January 24, 2023
From
Gibbs Law Group
Via
Business Wire
ROSEN, SKILLED INVESTOR COUNSEL, Encourages NeoGenomics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NEO
January 24, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against F45 Training, Silvergate, NeoGenomics, and Iris and Encourages Investors to Contact the Firm
January 23, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages NeoGenomics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NEO
January 21, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
Exposures
Financial
Legal
NEO INVESTOR ALERT: First and Only NeoGenomics Class Action Filed by Gibbs Law Group
January 19, 2023
From
Gibbs Law Group
Via
Business Wire
Why Jupiter Wellness Shares Are Trading Lower By Around 40%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
January 19, 2023
Gainers Genius Group Limited (NYSE: GNS) jumped 87% to $1.00. Genius Group authorized issue of special dividend and appointed Timothy Murphy to lead Illegal Trading Task Force.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.